Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for February 5th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 5th:

Thor Industries, Inc. (THO - Free Report) : This designer, manufacturer, and seller of recreational vehicles, and related parts and accessories has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.2% over the last 60 days.

 

Thor Industries’ shares gained 27.1% over the last one month compared with the S&P 500’s growth of 4.6%. The company possesses a Momentum Score of A.

 

PCB Bancorp (PCB - Free Report) : This bank holding company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.7% over the last 60 days.

 

PCB Bancorp Price and Consensus

PCB Bancorp Price and Consensus

PCB Bancorp price-consensus-chart | PCB Bancorp Quote

 

PCB Bancorp’s shares gained 24.7% over the last one month. The company possesses a Momentum Score of A.

 

Skyworks Solutions, Inc. (SWKS - Free Report) : This designer, developer, manufacturer, and marketer of proprietary semiconductor products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 37.9% over the last 60 days.

 

Skyworks’ shares gained 18.8% over the last one month. The company possesses a Momentum Score of A.

 

Delek Logistics Partners, LP (DKL - Free Report) : This owner and operator of logistics and marketing assets for crude oil, and intermediate and refined products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 48.4% over the last 60 days.

 

Delek Logistics’ shares gained 18.5% over the last one month. The company possesses a Momentum Score of A.

 

See the full list of top ranked stocks here.

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in